IN185197B - - Google Patents

Info

Publication number
IN185197B
IN185197B IN2509DE1996A IN185197B IN 185197 B IN185197 B IN 185197B IN 2509DE1996 A IN2509DE1996 A IN 2509DE1996A IN 185197 B IN185197 B IN 185197B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Chitra Dr Mandal
Diviya Sinha
Dilip Kumar Bhattacharya
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Priority to IN2509DE1996 priority Critical patent/IN185197B/en
Priority to US08/824,159 priority patent/US5925530A/en
Publication of IN185197B publication Critical patent/IN185197B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57426Specifically defined cancers leukemia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2509DE1996 1996-11-15 1996-11-15 IN185197B (nl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN2509DE1996 IN185197B (nl) 1996-11-15 1996-11-15
US08/824,159 US5925530A (en) 1996-11-15 1997-03-26 Simple method for the detection of minimal residual disease to predict relapse of acute lymphoblastic leukaemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2509DE1996 IN185197B (nl) 1996-11-15 1996-11-15

Publications (1)

Publication Number Publication Date
IN185197B true IN185197B (nl) 2000-12-02

Family

ID=11092784

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2509DE1996 IN185197B (nl) 1996-11-15 1996-11-15

Country Status (2)

Country Link
US (1) US5925530A (nl)
IN (1) IN185197B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191209B (nl) 1999-09-08 2003-10-04 Council Scient Ind Res
CN108823306A (zh) * 2017-05-03 2018-11-16 杭州赫玛生物科技有限公司 检测白血病细胞的系统和方法

Also Published As

Publication number Publication date
US5925530A (en) 1999-07-20

Similar Documents

Publication Publication Date Title
AR026662A2 (nl)
IN195165B (nl)
IN187317B (nl)
IN186357B (nl)
IN191523B (nl)
IN192561B (nl)
ITMI960494A0 (nl)
IN185197B (nl)
IN190230B (nl)
IN184300B (nl)
IN182579B (nl)
ITME960002A0 (nl)
ITMI960321A0 (nl)
BR7601346U (nl)
BR7600721U (nl)
ITMI960535V0 (nl)
ITMI960484A0 (nl)
CN3043305S (nl)
CN3047647S (nl)
CN3044346S (nl)
CN3044168S (nl)
CN3047249S (nl)
CN3047252S (nl)
CN3042589S (nl)
CN3042289S (nl)